Henlius e Intas reciben la opinión positiva del CHMP para HETRONIFLY® en los mercados europeos
Henlius e Intas reciben la opinión positiva del CHMP para HETRONIFLY® (aprobado como HANSIZHUANG en China) en los mercados europeos como tratamiento de primera línea para pacientes adultos con cáncer de pulmón de células pequeñas en estadio avanzado – HANSIZHUANG ® (serplulimab) fue el…
Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY® (approved as HANSIZHUANG in China) in European markets as First-Line Treatment for adult patients with Extensive-Stage Small Cell Lung Cancer
– HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – HETRONIFLY® (serplulimab) is expected to become the first anti-PD-1 monoclonal antibody available in Europe for first-line treatment of ES-SCLC AHMEDABAD, India,…
Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
HANSIZHUANG (serplulimab) is the world’s first anti-PD-1 mAb for first-line treatment of ES- SCLC – HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody available in Europe for first-line treatment of ES- SCLC – HANSIZHUANG (serplulimab) has…
Translumina Therapeutics, India’s largest domestic player in the coronary stents market, announces the initiation of direct operations in the UAE
NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its inception, the company has successfully established their own manufacturing capabilities and developed in-house product…
Cultivating a Culture of Peace: International Day of Peace Statement by Education Cannot Wait Executive Director Yasmine Sherif
NEW YORK, Sept. 21, 2024 /PRNewswire/ — The longing for peace transcends time, geography and religion. Based on justice, human rights and universal values outlined in the UN Charter, a culture of peace brings us all together in our common agenda for humanity. We can only co-exist by…
Ginseng Gives Back: Jung Kwan Jang Tesla Giveaway and Give a Gift of Health Initiative
– Celebrate Charity Day and Chuseok with JungKwanJang’s Tesla Giveaway and Give a Gift of Health Initiative CERRITOS, Calif., Sept. 20, 2024 /PRNewswire/ — Cerritos, CA – Korea Ginseng Corp. US (KGCUS) aka JungKwanJang is celebrating two significant occasions this September: the…
ORTHOFIX MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix Medical, Inc. – OFIX
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc. (NasdaqGS: OFIX), if they…
CROWDSTRIKE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CrowdStrike Holdings, Inc. – CRWD
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 30, 2024 to file lead plaintiff applications in a securities class action lawsuit against CrowdStrike Holdings, Inc. (the “Company”) (NasdaqGS:…
SPRINKLR SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sprinklr, Inc. – CXM
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 15, 2024 to file lead plaintiff applications in a securities class action lawsuit against Sprinklr, Inc. (NYSE: CXM), if they purchased the…
ARBOR REALTY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Arbor Realty Trust, Inc. – ABR
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 30, 2024 to file lead plaintiff applications in a securities class action lawsuit against Arbor Realty Trust, Inc. (“ABR” or the “Company”)…
METHODE ELECTRONICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Methode Electronics, Inc. – MEI
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Methode Electronics, Inc. (NYSE: MEI), if they…
WEBTOON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against WEBTOON Entertainment Inc. – WBTN
NEW ORLEANS, Sept. 20, 2024 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 4, 2024 to file lead plaintiff applications in a securities class action lawsuit against WEBTOON Entertainment Inc. (“Webtoon” or the “Company”)…